STEPHANIE JOHNSON: Open Payments
NPI 1255591665 · ATHENS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,489 in 50 payments from 20 companies in 2025. Trend: 2023 $1,383 · 2024 $1,465 · 2025 $1,489
Food & beverage: $1,309Education: $180
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 9 | $444 |
| Astellas Pharma US Inc | 5 | $197 |
| Ferring Pharmaceuticals Inc. | 7 | $190 |
| Sumitomo Pharma America, Inc. | 4 | $105 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $89 |
| Endo USA, Inc. | 4 | $88 |
| ABBVIE INC. | 4 | $83 |
| Verity Pharmaceuticals Inc. | 2 | $40 |
| Dendreon Pharmaceuticals LLC | 1 | $30 |
| Boston Scientific Corporation | 1 | $29 |
Products named: RYBREVANT, ERLEADA, ADSTILADRIN, Xtandi, Nubeqa, XIAFLEX, BOTOX, ORGOVYX.
Industry payments across GA — which companies pay providers there.
